In its new market study, Future Market Insights (FMI) estimates global cell culture media bags market will register impressive growth between 2022 and 2030, progressing at a stellar CAGR of 10.8%. Furthermore, the study projects that the market will surge past a global valuation of US$ 2.67 Bn by 2030. The report attributes the growth of the market to soaring demand for disposable packaging solutions in life sciences R&D activities and manufacturing of biopharmaceuticals.
Moreover, the emergence of innovative techniques such as four-layered films, which provide exceptional oxygen and moisture barrier properties, is also expected to boost demand.
Having analyzed the impact of the COVID-19 pandemic, the report opines that increasing health concerns and high emphasis on biopharmaceutical research will augur well for market growth during the assessment period.
COVID-19 Impact
The outbreak of COVID-19 is expected to positively influence the demand for cell culture media bags as players operating in the healthcare and pharmaceutical sectors emphasize on high quality and safe packaging and storing solutions. Moreover, an upsurge in the number of studies and researches during the pandemic to develop a vaccine is, in turn, propelling demand for cell culture media bags.
Likewise, the need for disposable and single-use solutions for applications such as large-scale purification, cell storage, protein purification, and polishing applications in the biopharmaceutical market will continue to offer remunerative opportunities to market players through the pandemic period.
Request Sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-12670
List Of Key Players Covered in Cell Culture Media Bags Market are:
- Parker Hannifin Corp
- Pall Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
- GE Healthcare Inc.
Competitive Landscape:
In this fast-growing industry, partnerships and collaborations, product launches, expansions, and other strategies have been used to gain a major piece of the cell culture media bags market.
To meet the increased demand for bioprocess manufacturing activities, market participants are concentrating on up-scaling media bag production. In addition, producers are tackling problems and improved features of bags such as four-layered films that provide stronger oxygen and moisture barriers to the properties.
In this vein, Thermo Fisher Scientific released the CEDIA Mitragynine (Kratom) Assay, a novel immunoassay for kratom alkaloid mitragynine screening designed specifically for criminal justice and forensic purposes.Throughout the projection period, continuous product innovations will continue to define the competitive landscape of the market. Furthermore, industry participants are concentrating their efforts on producing products for specific end uses.
Speak to our Research Expert @
https://www.futuremarketinsights.com/ask-question/rep-gb-12670
Key Takeaways
- 2D bag designs are expected to account for over half of the market value, owing to their high flexibility
- Very large bags (>3000 ml) will remain the most sought out size, owing to low contamination properties
- By host cell, the bacterial cell segment is projected to account for the majority of market value, ascribed to an increasing number of studies on diseases caused by bacteria.
- Biopharmaceutical manufacturing will remain a key end-use segment, capturing over 2/3rds of market value through the forecast period.
- US will remain the largest market for cell culture media bags globally.
“Market players are investing in new product innovation and are focusing on procuring FDA approvals to facilitate wide-scale deployment,” remarks FMI analyst.
Who is Winning?
Cell culture media bags manufacturers are focusing on developing solutions that address the key challenges such as recycling of multilayer flexible packaging consisting of plastic and barrier materials. Moreover, new product development and strategic partnerships have been identified as key growth strategies adopted by market players.
- In April 2019, Thermo Fisher Scientific launched a new immunoassay – CEDIA Mitragynine (Kratom) Assay – for kratom alkaloid mitragynine screening solely for criminal justice and forensic applications.
- In August, 2015, Rim Bio partnered with Playmouth based Sentrol for sales and distribution of its single-use bio containers across the United States.
FMI’s report includes profiles of some of the most prominent names in the market including Parker Hannifin Corp, Pall Corporation, Sartorious AG, Thermo Fisher Scientific Inc., and GE Healthcare Inc.
Report Customization available @
https://www.futuremarketinsights.com/customization-available/rep-gb-12670
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com